查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
分子診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按疾病領域、技術、產品和服務、最終用戶和地理位置
市場調查報告書
商品編碼
1362395

分子診斷市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按疾病領域、技術、產品和服務、最終用戶和地理位置

Molecular Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Area, Technology, Product & Services, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 272 Pages | 訂單完成後即時交付

價格

分子診斷市場規模預計將從2022年的1817387萬美元增至2030年的4587565萬美元；預計2022年至2030年年複合成長率為 12.3%。本報告強調了市場的普遍趨勢以及驅動和阻礙分子診斷市場成長的因素。市場的成長歸因於新產品的開發、即時檢測需求的增加以及相關疾病盛行率的飆升。然而，與分子測試相關的限制阻礙了市場的成長。

個人化醫療中的分子診斷促進未來幾年分子診斷市場的成長

隨著高通量技術的進步，基因組研究變得更加方便且具有成本效益。分子診斷在臨床實驗室中變得越來越不可或缺，因為這些試劑盒和測試可提供快速的檢測結果，而傳統測試在某些情況下還包括在實驗室條件下培養微生物。使用精準醫學，根據每位患者獨特的基因組成、生活方式和環境，為其量身定做醫療治療和干涉措施。分子診斷在這種方法中發揮重要作用，因為它能夠識別影響患者治療相關決策的特定生物標記、基因突變和基因表現模式。藥物開發越來越依賴分子診斷。廣泛的分子影像技術用於篩檢、檢測、診斷、治療和評估異質性；制定進步計劃；檢查分子特徵；並監測患者的治療結果。此外，分子影像可以幫助檢測微小腫瘤並評估其活動，為腫瘤學個人化醫療、研究、臨床試驗和醫療實踐的發展和擴展做出重大貢獻。高通量基因分型平台可用於檢測臨床樣本中的遺傳畸變，次世代定序可用於識別所有類型的致癌變化。將這些技術引進臨床實踐將能夠識別每個患者的分子標靶，並有助於追蹤疾病的分子進展。透過這些方法，癌症患者將能夠接受個人化醫療。因此，隨著技術的不斷發展，分子診斷市場似乎有著光明的前景。

與分子測試相關的限制阻礙了市場成長

分子檢測的結果取決於採樣和檢測過程、技術人員的技能等，這可能會導致檢測結果的變化。此外，有些測試程序需要更長的時間才能產生結果。很多時候，檢測試劑盒可能會顯示假陽性或陰性結果。因此，與分子測試相關的不確定性阻礙了它們的採用，特別是在危及生命的疾病的診斷和治療方面。對現場檢測的認知有限，特別是在發展中國家和低度開發國家，也阻礙了市場的成長。此外，癌症和病毒感染等適應症的分子檢測成本以及供應短缺阻礙分子診斷市場的發展。

分子診斷市場，依疾病領域洞察

根據疾病領域，分子診斷市場分為腫瘤學、傳染病、基因檢測、心臟病、免疫系統疾病等。

傳染病領域在2022年佔據最大的市場佔有率。然而，腫瘤領域預計在預測期內年複合成長率最高，達到 12.6%。腫瘤分子診斷是暴露遺傳物質、蛋白質、相關分子並基於傳遞腫瘤訊息的 DNA、RNA 和蛋白質評估代謝功能、藥物代謝和疾病誘導的測試。根據世界衛生組織(WHO)統計，2020年癌症將導致約1000萬人死亡。此外，根據美國癌症協會2021年的統計資料，到2040年，全球癌症負擔預計將增至2750萬新發病例和1630萬癌症患者。如此高的數字表明，據估計癌症發病率不斷上升，對原始診斷和預防性治療的需求不斷增加。診斷癌症的方法有很多種，包括PCR、INAAT和NGS等。其中PCR(聚合酶鍊式反應)的概念導致了臨床DNA檢測的巨大進步。基於 PCR 的方法需要簡單的儀器和基礎設施，僅利用微量的生物材料，並且與臨床常規廣泛協調。

雖然PCR的成本很高，但最準確的即時PCR方法(準確率超過99%)是包括韓國在內的許多已開發國家大量使用的方法，而發展中國家則大量採用傳統PCR(準確率超過90%) ，比即時 PCR 更便宜。由於其他選擇的價格較高，低度開發國家通常使用快速 PCR(準確度為 60 - 70%)。在腫瘤分子診斷領域，NGS 是另一項成長最快的技術。許多公司加緊努力，以經濟地利用這項技術。例如，2021年 4月，Illumina Inc. 宣布與 Kartos Therapeutics 合作，共同開發基於 NGS 的 TP53 伴隨診斷，這有助於降低與儲存和管理基因組資料相關的成本。

基於技術的洞察分子診斷市場

依技術，分子診斷市場分為聚合酶鍊式反應、等溫核酸擴增技術、DNA定序與二代定序、DNA微陣列、原位雜合技術等。 PCR 進一步細分為 RT-PCR、qPCR、多重 PCR 等。 PCR 細分市場在2022年佔據最大的市場佔有率，預計在預測期內該細分市場的年複合成長率將達到 12.7%的最高水準。 PCR主要用於複製核酸鏈來製備或擴增DNA。熱循環儀用於在擴增過程中使 DNA 鏈變性和退火，並與酶、核苷酸和緩衝液等試劑一起建立新型 DNA。此技術廣泛應用於基因功能分析、遺傳診斷、DNA克隆、親子鑑定、傳染病檢測、法醫學等領域。聚合酶鍊式反應分為傳統PCR、即時PCR和數位PCR。然而，疫情期間持續的技術進步和需求激增將繼續推動印度和其他亞太國家對 PCR 檢測的需求。結核病、肝炎、流感和嚴重感染等疾病的持續流行將促進 PoC 分子診斷產業的發展趨勢。目前，新型冠狀病毒肺炎(COVID-19)大流行的爆發將為市場創造利潤豐厚的成長空間，因為這種方法對於在沒有表現出疾病跡象的個體中檢測病毒非常重要。 PCR 精湛的靈敏度、相對簡單性和成本效益使 PCR 與其他核酸擴增技術區分開來，鞏固了其作為分子實驗室中流砥柱的地位。由於PCR技術的不斷研究和發展，PCR已成為各種臨床和診斷應用或檢查不可或缺的工具。因此，它為各種傳染病的快速照護端診斷提供了許多機會。例如，F. Hoffmann-La Roche Ltd 持續致力於數位 PCR(dPCR)技術的進步。 dPCR已將其應用擴展到臨床領域，並已成為重要的臨床工具。 dPCR 提供超靈敏和絕對的核酸定量，無需參考標準。因此，它為標準化和比較實驗室之間的結果提供了更廣泛的方面。在大流行爆發期間，Mylab PathoDetect COVID-19 定性PCR 試劑盒是先行者之一，是該國首批獲得中央藥品標準商業批准的企業之一控制組織(CDSCO)去年。獲得批准後，Mylab 與生物技術巨頭印度血清研究所和當地公司 AP Globale 合作。 PCR再細分為RT-PCR、qPCR、多重PCR等。分子診斷市場，透過基於購買模式的洞察。

根據產品和服務，分子診斷市場分為檢測和試劑盒、儀器以及服務和軟體。到2022年，檢測和試劑盒領域將佔據最大的市場佔有率，預計在預測期內將實現市場上最高的年複合成長率。分子診斷分析是廣泛使用的分析技術之一。快速分子檢測、逆轉錄聚合酶鏈反應(RT-PCR)、抗原等各種類型的檢測用於識別和分析各種疾病，例如流感 COVID 19、結核病等。作為產品創新和業務策略的一部分，市場參與者為不同的檢測試劑盒提供診斷試劑盒。區域參與者積極參與與該領域相關的業務發展。例如，2021年 9月，Mylab Discovery Solutions 收購了 Sanskritech 的多數股權，Sanskritech 是 Swayam 平台的開發商，Swayam 是一種照護端測試系統，可以在照護端執行約 70 項測試。此外，在新冠病毒大流行中，全球各個市場參與者都透過其區域業務部門提供他們的試劑盒。基於上述因素，預計該部門在預測期內將做出顯著貢獻。

根據最終用戶，分子診斷市場分為醫院和診所、診斷實驗室、研究和學術機構等。2022年，診斷實驗室領域佔據最大的市場佔有率。此外，由於各地區各種醫療狀況的檢測和診斷數量增加，預計該領域的需求在2022年至2030年期間將以 12.7%的最快年複合成長率成長。診斷實驗室是分子診斷產品和服務的主要用途。它擁有符合監管要求的完善設施。實驗室使用所有可能的分子診斷產品和服務。使用不同的儀器、試劑、方法和技術對從患者身上採集的樣本進行分析和研究。這些實驗室為醫院、診所、家庭護理等提供服務。慢性病、傳染病的盛行率不斷上升，個別研究人員外包分子診斷活動是預測期內支持該細分市場成長的因素之一。

分子診斷市場：競爭格局與主要發展

Abbott Laboratories、Agilent Technologies Inc.、Thermo Fisher Scientific Inc.、F. Hoffman-La Roche Ltd.、Qiagen NV、bioMerieux SA、Illumnia Inc.、Danaher、Siemens Healthineers AG、Novartis AG 和 TBG Diagnostics Limited 均屬於領先公司經營分子診斷市場。

市場參與者向市場推出新產品。下面舉幾個例子：

2023年 1月，Agilent將與 Quest Diagnostics 合作，擴大 Agilent Resolution ctDx FIRST 液體活體組織切片測試的使用範圍。 Quest 和Agilent之間的協議將使 ctDx FIRST 廣泛採用，這是一種在華盛頓 Resolution Bioscience CLIA 實驗室進行的單點上市前批准(ssPMA)測試。

2023年 7月，Thermo Fisher推出了用於分子診斷實驗室的新軟體。該軟體有助於簡化常規診斷測試，實現標準化並快速獲得結果。它可以透過在單一介面中連接工作流程步驟來增強實驗室動態回應快速變化的測試環境的潛力。

2021年10月，Agilent科技公司宣布其Ki-67 IHC MIB-1 pharmDx(Dako Omnis)現已獲得FDA 批准，可用於識別疾病復發高風險的早期乳癌(EBC)患者，對於這些患者，可以使用佐劑Verzenio(abemaciclib)與內分泌治療相結合的治療。

目錄

第1章 簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第2章 執行摘要

  • 重要見解

第3章 研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第4章 分子診斷市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲PEST分析
    • 亞太地區 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中東和非洲 PEST 分析

第5章 分子診斷市場 - 主要產業動態

  • 主要市場促進因素：
    • 新產品的開發和即時檢測需求的增加
    • 相關疾病的盛行率激增
  • 市場限制
    • 與分子測試相關的局限性
  • 市場機會
    • 分子診斷技術的進步
  • 未來的趨勢
    • 個性化醫療中的分子診斷
  • 影響分析：

第6章 分子診斷市場 - 全球市場分析

  • 分子診斷市場收入，2022 -2030

第7章 全球分子診斷市場 -2030年收入與預測 - 按疾病領域

  • 概述
  • 2022年和2030年分子診斷市場收入佔有率，按疾病領域分類(%)
  • 腫瘤學
  • 傳染病
  • 基因檢測
  • 心臟病
  • 免疫系統疾病
  • 其他

第8章 全球分子診斷市場 - 收入與2030年預測 - 依技術分類

  • 概述
  • 2022年和2030年依技術分類的分子診斷市場收入佔有率(%)
  • 聚合酶鍊式反應
  • 等溫核酸擴增技術(INAAT)
  • DNA 定序和二代定序(NGS)
  • DNA微陣列
  • 原位雜合技術(ISH)
  • 其他

第9章 全球分子診斷市場 - 收入和2030年預測 - 依產品和服務

  • 概述
  • 2022年和2030年分子診斷市場收入佔有率(依產品和服務分類)(%)
  • 檢測方法和試劑盒
  • 儀器
  • 服務和軟體

第10章 全球分子診斷市場 - 收入和2030年預測 - 依最終用戶

  • 概述
  • 2022年和2030年分子診斷市場收入佔有率(依最終用戶分類)(%)
  • 醫院和診所
  • 診斷實驗室
  • 研究和學術機構
  • 其他

第11章 分子診斷市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 新加坡
    • 馬來西亞
    • 菲律賓
    • 泰國
    • 印尼
    • 越南
    • 亞太地區其他地區
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章 Covid-19 前後的影響

  • Covid-19 前後的影響

第13章 分子診斷市場產業格局

  • 概述
  • 市場上公司採取的成長策略(%)
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第14章 分子診斷市場，主要公司概況

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG
  • TBG Diagnostics Limited

第15章 附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00003124

The molecular diagnostics market size is expected to reach US$ 45,875.65 million by 2030 from US$ 18,173.87 million in 2022; it is estimated to register a CAGR of 12.3% from 2022 to 2030. The report highlights trends prevailing in the market and the factors driving and hindering the molecular diagnostics market growth. The growth of the market is attributed to the development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases. However, limitations associated with molecular testing hinders the market growth.

Molecular Diagnostics in Personalized Medicine for Molecular Diagnostics Market Growth in the Upcoming Years

With progress in high-throughput techniques, genome research has become more convenient and cost effective. Molecular diagnostics is becoming increasingly indispensable in clinical laboratories as these kits and tests provide rapid detection results as opposed to the conventional tests, which also involved culturing microbes in laboratory conditions in some cases. Using precision medicine, medical treatments and interventions are tailored to each patient based on their unique genetic makeup, lifestyle, and environment. Molecular diagnostics plays an important role in this approach, as it enables the identification of specific biomarkers, genetic mutations, and gene expression patterns that impact decision-making related to the treatment of patients. Drug development has become increasingly dependent on molecular diagnostics. A wide range of molecular imaging techniques are used in screening, detecting, diagnosing, treating, and assessing heterogeneity; making progression plans; examining molecular characteristics; and monitoring patient outcomes. In addition, molecular imaging can aid in the detection of tiny tumors and assessment of their activities, contributing significantly to the development and expansion of personalized medicine, research, clinical trials, and medical practice in oncology. A high-throughput genotyping platform can be used to detect genetic aberrations in clinical samples, and next-generation sequencing can be used to identify all types of cancer-causing changes. The introduction of these techniques into clinical practice would enable the identification of molecular targets in each patient, along with facilitating the tracking of the molecular progression of diseases. With these approaches, cancer patients will be able to receive personalized medicine. Thus, with technology ever evolving, the market for molecular diagnostics seems to have a bright future.

Limitations Associated with Molecular Testing Hampers the Market Growth

The outcomes of molecular testing depend on sampling and testing processes, technicians' skill sets, etc., which may lead to variations in test results. Further, some test procedures take longer for producing results. Several times, test kits may show false positive or negative results. Thus, uncertainties associated with molecular tests hamper their adoption, especially in diagnostics and treatment of life-threatening diseases. The limited awareness of point-of-care tests, particularly in developing and underdeveloped countries, also hinders the market growth. In addition, the cost of molecular testing for indications such as cancer and viral infections, and the shortage of supplies are hampering the molecular diagnostics market.

Molecular Diagnostics Market, By Disease Area Insights

Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others.

The infectious disease segment held the largest market share in 2022. However, oncology segment is anticipated to register the highest CAGR of 12.6% during the forecast period. Oncology molecular diagnostics are tests that expose inherited material, proteins, associated molecules and assess metabolic functions, drug metabolism, and disease induction grounded on DNA, RNA, and proteins that deliver oncological information. As stated by World Health Organization (WHO), cancer reckoned for roughly 10 million demises in 2020. Furthermore, as per the 2021 statistics by the American Cancer Society, by 2040, the global burden of carcinoma is anticipated to raise to 27.5 million fresh cases and 16.3 million cancer deceases. Such like high figures denote that the evaluated rising frequency of cancer is chipping into the accelerating requirement for primitive diagnosis and preventive cure. There are numerous methods to diagnose carcinoma comprehending PCR, INAAT, and NGS etc. Among all the conception of PCR (polymerase chain reaction) led to an enormous advancement in clinical DNA testing. PCR-based methodologies demand straightforward instrumentation and infrastructure, exploit only minute quantities of biological material and are extensively harmonious with clinical routine.

Although the cost of PCR is lofty, most accurate real-time PCR approach (with more than 99% accuracy) is the one substantially used in numerous developed countries including Korea, while developing countries substantially exploit the conventional PCR (more than 90% accuracy), which is affordable than real-time PCR. Because of the high prices of the other options, underdeveloped countries generally use Rapid PCR (60 - 70% accuracy). Within the field of oncology molecular diagnostics, NGS is another technology flaunting the loftiest rate of growth. Numerous companies are working intensely to make economic use of this technology. For instance, in April 2021, Illumina Inc. blazoned its partnership with Kartos Therapeutics to co-develop an NGS- Based TP53 Companion Diagnostic, which aided to reduce the costs associated with storing and managing of genomic data.

Molecular Diagnostics Market, By Technology-Based Insights

Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. The PCR is further sub segmented into RT-PCR, qPCR, Multiplex PCR, and others. The PCR segment held the largest share of the market in 2022, and the same segment is anticipated to register the highest CAGR of 12.7% in the market during the forecast period. PCR is mainly used to make or amplify DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. This technique is widely used in various application such as functional analysis of genes, diagnosis of hereditary, DNA cloning, paternity testing, detection of infectious diseases, and forensic sciences. Polymerase chain reaction has been classified into traditional PCR, real-time PCR, and digital PCR. However, ongoing technological advances and surging demand amid the pandemic will continue to fuel the need for PCR tests in India as well as other Asia Pacific countries. Consistent prevalence of diseases like tuberculosis, Hepatitis, flu, and serious infections will foster PoC molecular diagnostic industry trends. Presently, the outbreak of novel COVID-19 pandemic would create lucrative growth aspects for the market as this approach is highly critical to detect virus in individuals who exhibit no symptoms of signs of disease. PCR's exquisite sensitivity, relative simplicity, and cost-effectiveness makes PCR stand apart from other nucleic acid amplification techniques, cementing it as a mainstay in molecular laboratories. PCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of Digital PCR (dPCR) techniques. dPCR has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories.During pandemic outbreak, one of the first mover startup, Mylab PathoDetect COVID-19 Qualitative PCR kit was among the first in the country to receive commercial approval from the Central Drugs Standard Control Organisation (CDSCO) last year. Following the approval, Mylab had partnered with biotech giant Serum Institute of India and local firm AP Globale. PCR is further sub-segmented into RT-PCR, qPCR, multiplex PCR and others. Molecular Diagnostics Market, By Purchase Mode-Based Insights.

Based on product & services, the molecular diagnostics market is segmented into assays & kits, instruments, and services & software. The assays and kits segment are held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during the forecast period. Molecular Diagnostics assays are among the widely used technique for analysis. Various types of assays such as rapid molecular assays, reverse transcription-polymerase chain reaction (RT-PCR), antigens, and others are used to identify and analyze various diseases such as influenza COVID 19, tuberculosis, and others. As part of product innovation and business strategies, the market players offer diagnostic kits for different test kits. The regional players are actively involved in business development related to the segment. For instance, In September 2021, Mylab Discovery Solutions acquired a majority stake in Sanskritech, developer of a platform Swayam a point of care testing system that can perform about 70 tests on the point. Moreover, in the COVID19 pandemic, various global market players offer their kits through their regional business divisions. Based on the above factors, the segment is expected to contribute remarkably during the forecast period.

Based on end user, the molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and others. In 2022, the diagnostic laboratories segment held the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 12.7% during 2022 to 2030, owing to the rise in the detection and diagnosis of various medical conditions across the regions. Diagnostic laboratories are the primary uses for molecular diagnostics products and services. It has well-established facilities as per the regulatory requirements. The laboratories use all possible molecular diagnostic products and services. The sample collected from the patients is analyzed and studied using different instruments, reagents, methods, and technologies. The labs provide services to hospitals, clinics, at-home care, and others. The increasing prevalence of chronic diseases, infectious diseases, outsourcing the molecular diagnostics activities by individual researchers are among the factors supporting the segment growth during the forecast period.

Molecular Diagnostics Market: Competitive Landscape and Key Developments

Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc, F. Hoffman-La Roche Ltd., Qiagen NV, bioMerieux SA, Illumnia Inc., Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are among the leading companies operating in the molecular diagnostics market.

Market players are launching new products to the market. Below are few instances:

In January 2023, Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test. The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Washington.

In July 2023, Thermo Fisher launched new software for molecular diagnostics labs. This software helps in streamlining routine diagnostics testing for standardization and rapid time-to-results. It can enhance the potential of a lab to dynamically respond to quickly changing testing environments by connecting workflow steps within a single interface.

In October 2021, Agilent Technologies Inc. has announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio (abemaciclib) in combination with endocrine therapy.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the molecular diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - Global Market Analysis

  • 6.1 Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Molecular Diagnostics Market - Geographical Analysis

  • 11.1 North America Molecular Diagnostics Market, Revenue And Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America Molecular Diagnostics Market, by Disease Area
    • 11.1.4 North America Molecular Diagnostics Market, by Technology
      • 11.1.4.1 North America Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
    • 11.1.5 North America Molecular Diagnostics Market, by Product and Services
    • 11.1.6 North America Molecular Diagnostics Market, by End User
      • 11.1.6.1 North America Molecular Diagnostics Market, by Country
    • 11.1.7 US
      • 11.1.7.1 Overview
    • 11.1.8 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.9 US Molecular Diagnostics Market, by Disease Area
    • 11.1.10 US Molecular Diagnostics Market, by Technology
      • 11.1.10.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
    • 11.1.11 US Molecular Diagnostics Market, by Product and Services
    • 11.1.12 US Molecular Diagnostics Market, by End User
    • 11.1.13 Canada
      • 11.1.13.1 Overview
    • 11.1.14 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.15 Canada Molecular Diagnostics Market, by Disease Area
    • 11.1.16 Canada Molecular Diagnostics Market, by Technology
      • 11.1.16.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.17 Canada Molecular Diagnostics Market, by Product and Services
    • 11.1.18 Canada Molecular Diagnostics Market, by End User
    • 11.1.19 Mexico
      • 11.1.19.1 Overview
    • 11.1.20 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.21 Mexico Molecular Diagnostics Market, by Disease Area
    • 11.1.22 Mexico Molecular Diagnostics Market, by Technology
      • 11.1.22.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.23 Mexico Molecular Diagnostics Market, by Product and Services
    • 11.1.24 Mexico Molecular Diagnostics Market, by End User
  • 11.2 Europe Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Molecular Diagnostics Market, by Disease Area
    • 11.2.4 Europe Molecular Diagnostics Market, by Technology
      • 11.2.4.1 Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.5 Europe Molecular Diagnostics Market, by Product and Services
    • 11.2.6 Europe Molecular Diagnostics Market, by End User
      • 11.2.6.1 Europe Molecular Diagnostics Market by Country
    • 11.2.7 Germany
      • 11.2.7.1 Overview
    • 11.2.8 Germany Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.9 Germany Molecular Diagnostics Market, by Disease Area
    • 11.2.10 Germany Molecular Diagnostics Market, by Technology
      • 11.2.10.1 Germany Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.11 Germany Molecular Diagnostics Market, by Product and Services
    • 11.2.12 Germany Molecular Diagnostics Market, by End User
    • 11.2.13 UK
      • 11.2.13.1 Overview
    • 11.2.14 UK Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.15 UK Molecular Diagnostics Market, by Disease Area
    • 11.2.16 UK Molecular Diagnostics Market, by Technology
      • 11.2.16.1 UK Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.17 UK Molecular Diagnostics Market, by Product and Services
    • 11.2.18 UK Molecular Diagnostics Market, by End User
    • 11.2.19 France
      • 11.2.19.1 Overview
    • 11.2.20 France Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.21 France Molecular Diagnostics Market, by Disease Area
    • 11.2.22 France Molecular Diagnostics Market, by Technology
      • 11.2.22.1 France Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.23 France Molecular Diagnostics Market, by Product and Services
    • 11.2.24 France Molecular Diagnostics Market, by End User
    • 11.2.25 Italy
      • 11.2.25.1 Overview
    • 11.2.26 Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.27 Italy Molecular Diagnostics Market, by Disease Area
    • 11.2.28 Italy Molecular Diagnostics Market, by Technology
      • 11.2.28.1 Italy Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.29 Italy Molecular Diagnostics Market, by Product and Services
    • 11.2.30 Italy Molecular Diagnostics Market, by End User
    • 11.2.31 Spain
      • 11.2.31.1 Overview
    • 11.2.32 Spain Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.33 Spain Molecular Diagnostics Market, by Disease Area
    • 11.2.34 Spain Molecular Diagnostics Market, by Technology
      • 11.2.34.1 Spain Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
        • 11.2.34.1.1 Spain Molecular Diagnostics Market, by Product and Services
    • 11.2.35 Spain Molecular Diagnostics Market, by End User
    • 11.2.36 Rest of Europe
      • 11.2.36.1 Overview
    • 11.2.37 Rest of Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.38 Rest of Europe Molecular Diagnostics Market, by Disease Area
    • 11.2.39 Rest of Europe Molecular Diagnostics Market, by Technology
      • 11.2.39.1 Rest of Europe Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.40 Rest of Europe Molecular Diagnostics Market, by Product and Services
    • 11.2.41 Rest of Europe Molecular Diagnostics Market, by End User
  • 11.3 Asia Pacific Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific Molecular Diagnostics Market, by Disease Area
    • 11.3.4 Asia Pacific Molecular Diagnostics Market, by Technology
      • 11.3.4.1 Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.5 Asia Pacific Molecular Diagnostics Market, by Product and Services
    • 11.3.6 Asia Pacific Molecular Diagnostics Market, by End User
      • 11.3.6.1 Asia Pacific Molecular Diagnostics Market by Country
    • 11.3.7 China
      • 11.3.7.1 Overview
    • 11.3.8 China Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.9 China Molecular Diagnostics Market, by Disease Area
    • 11.3.10 China Molecular Diagnostics Market, by Technology
      • 11.3.10.1 China Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.11 China Molecular Diagnostics Market, by Product and Services
    • 11.3.12 China Molecular Diagnostics Market, by End User
    • 11.3.13 Japan
      • 11.3.13.1 Overview
    • 11.3.14 Japan Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.15 Japan Molecular Diagnostics Market, by Disease Area
    • 11.3.16 Japan Molecular Diagnostics Market, by Technology
      • 11.3.16.1 Japan Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.17 Japan Molecular Diagnostics Market, by Product and Services
    • 11.3.18 Japan Molecular Diagnostics Market, by End User
    • 11.3.19 India
      • 11.3.19.1 Overview
    • 11.3.20 India Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.21 India Molecular Diagnostics Market, by Disease Area
    • 11.3.22 India Molecular Diagnostics Market, by Technology
      • 11.3.22.1 India Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.23 India Molecular Diagnostics Market, by Product and Services
    • 11.3.24 India Molecular Diagnostics Market, by End User
    • 11.3.25 Australia
      • 11.3.25.1 Overview
    • 11.3.26 Australia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.27 Australia Molecular Diagnostics Market, by Disease Area
    • 11.3.28 Australia Molecular Diagnostics Market, by Technology
      • 11.3.28.1 Australia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.29 Australia Molecular Diagnostics Market, by Product and Services
    • 11.3.30 Australia Molecular Diagnostics Market, by End User
    • 11.3.31 South Korea
      • 11.3.31.1 Overview
    • 11.3.32 South Korea Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.33 South Korea Molecular Diagnostics Market, by Disease Area
    • 11.3.34 South Korea Molecular Diagnostics Market, by Technology
      • 11.3.34.1 South Korea Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.35 South Korea Molecular Diagnostics Market, by Product and Services
    • 11.3.36 South Korea Molecular Diagnostics Market, by End User
    • 11.3.37 Singapore
      • 11.3.37.1 Overview
    • 11.3.38 Singapore Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.39 Singapore Molecular Diagnostics Market, by Disease Area
    • 11.3.40 Singapore Molecular Diagnostics Market, by Technology
      • 11.3.40.1 Singapore Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.41 Singapore Molecular Diagnostics Market, by Product and Services
    • 11.3.42 Singapore Molecular Diagnostics Market, by End User
    • 11.3.43 Malaysia
      • 11.3.43.1 Overview
    • 11.3.44 Malaysia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.45 Malaysia Molecular Diagnostics Market, by Disease Area
    • 11.3.46 Malaysia Molecular Diagnostics Market, by Technology
      • 11.3.46.1 Malaysia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.47 Malaysia Molecular Diagnostics Market, by Product and Services
    • 11.3.48 Malaysia Molecular Diagnostics Market, by End User
    • 11.3.49 Philippines
      • 11.3.49.1 Overview
    • 11.3.50 Philippines Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.51 Philippines Molecular Diagnostics Market, by Disease Area
    • 11.3.52 Philippines Molecular Diagnostics Market, by Technology
      • 11.3.52.1 Philippines Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.53 Philippines Molecular Diagnostics Market, by Product and Services
    • 11.3.54 Philippines Molecular Diagnostics Market, by End User
    • 11.3.55 Thailand
      • 11.3.55.1 Overview
    • 11.3.56 Thailand Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.57 Thailand Molecular Diagnostics Market, by Disease Area
    • 11.3.58 Thailand Molecular Diagnostics Market, by Technology
      • 11.3.58.1 Thailand Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.59 Thailand Molecular Diagnostics Market, by Product and Services
    • 11.3.60 Thailand Molecular Diagnostics Market, by End User
    • 11.3.61 Indonesia
      • 11.3.61.1 Overview
    • 11.3.62 Indonesia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.63 Indonesia Molecular Diagnostics Market, by Disease Area
    • 11.3.64 Indonesia Molecular Diagnostics Market, by Technology
      • 11.3.64.1 Indonesia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.65 Indonesia Molecular Diagnostics Market, by Product and Services
    • 11.3.66 Indonesia Molecular Diagnostics Market, by End User
    • 11.3.67 Vietnam
      • 11.3.67.1 Overview
    • 11.3.68 Vietnam Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.69 Vietnam Molecular Diagnostics Market, by Disease Area
    • 11.3.70 Vietnam Molecular Diagnostics Market, by Technology
      • 11.3.70.1 Vietnam Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.71 Vietnam Molecular Diagnostics Market, by Product and Services
    • 11.3.72 Vietnam Molecular Diagnostics Market, by End User
    • 11.3.73 Rest of Asia Pacific
      • 11.3.73.1 Overview
    • 11.3.74 Rest of Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.75 Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area
    • 11.3.76 Rest of Asia Pacific Molecular Diagnostics Market, by Technology
      • 11.3.76.1 Rest of Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.77 Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services
    • 11.3.78 Rest of Asia Pacific Molecular Diagnostics Market, by End User
  • 11.4 Middle East & Africa Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa Molecular Diagnostics Market, by Disease Area
    • 11.4.4 Middle East & Africa Molecular Diagnostics Market, by Technology
      • 11.4.4.1 Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.5 Middle East & Africa Molecular Diagnostics Market, by Product and Services
    • 11.4.6 Middle East & Africa Molecular Diagnostics Market, by End User
      • 11.4.6.1 Middle East & Africa Molecular Diagnostics Market by Country
    • 11.4.7 UAE
      • 11.4.7.1 Overview
    • 11.4.8 UAE Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.9 UAE Molecular Diagnostics Market, by Disease Area
    • 11.4.10 UAE Molecular Diagnostics Market, by Technology
      • 11.4.10.1 UAE Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.11 UAE Molecular Diagnostics Market, by Product and Services
    • 11.4.12 UAE Molecular Diagnostics Market, by End User
    • 11.4.13 Saudi Arabia
      • 11.4.13.1 Overview
    • 11.4.14 Saudi Arabia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.15 Saudi Arabia Molecular Diagnostics Market, by Disease Area
    • 11.4.16 Saudi Arabia Molecular Diagnostics Market, by Technology
      • 11.4.16.1 Saudi Arabia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.17 Saudi Arabia Molecular Diagnostics Market, by Product and Services
    • 11.4.18 Saudi Arabia Molecular Diagnostics Market, by End User
    • 11.4.19 South Africa
      • 11.4.19.1 Overview
    • 11.4.20 South Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.21 South Africa Molecular Diagnostics Market, by Disease Area
    • 11.4.22 South Africa Molecular Diagnostics Market, by Technology
      • 11.4.22.1 South Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.23 South Africa Molecular Diagnostics Market, by Product and Services
    • 11.4.24 South Africa Molecular Diagnostics Market, by End User
    • 11.4.25 Rest of Middle East & Africa
      • 11.4.25.1 Overview
    • 11.4.26 Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.27 Rest of Middle East & Africa Molecular Diagnostics Market, by Disease Area
    • 11.4.28 Rest of Middle East & Africa Molecular Diagnostics Market, by Technology
      • 11.4.28.1 Rest of Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.29 Rest of Middle East & Africa Molecular Diagnostics Market, by Product and Services
    • 11.4.30 Rest of Middle East & Africa Molecular Diagnostics Market, by End User
  • 11.5 South & Central America Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Molecular Diagnostics Market, by Disease Area
    • 11.5.4 South & Central America Molecular Diagnostics Market, by Technology
      • 11.5.4.1 South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.5 South & Central America Molecular Diagnostics Market, by Product and Services
    • 11.5.6 South & Central America Molecular Diagnostics Market, by End User
      • 11.5.6.1 South & Central America Molecular Diagnostics Market by Country
    • 11.5.7 Brazil
      • 11.5.7.1 Overview
    • 11.5.8 Brazil Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.9 Brazil Molecular Diagnostics Market, by Disease Area
    • 11.5.10 Brazil Molecular Diagnostics Market, by Technology
      • 11.5.10.1 Brazil Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.11 Brazil Molecular Diagnostics Market, by Product and Services
    • 11.5.12 Brazil Molecular Diagnostics Market, by End User
    • 11.5.13 Argentina
      • 11.5.13.1 Overview
    • 11.5.14 Argentina Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.15 Argentina Molecular Diagnostics Market, by Disease Area
    • 11.5.16 Argentina Molecular Diagnostics Market, by Technology
      • 11.5.16.1 Argentina Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.17 Argentina Molecular Diagnostics Market, by Product and Services
    • 11.5.18 Argentina Molecular Diagnostics Market, by End User
    • 11.5.19 Rest of South & Central America
      • 11.5.19.1 Overview
    • 11.5.20 Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.21 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
    • 11.5.22 Rest of South & Central America Molecular Diagnostics Market, by Technology
      • 11.5.22.1 Rest of South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.23 Rest of South & Central America Molecular Diagnostics Market, by Product and Services
    • 11.5.24 Rest of South & Central America Molecular Diagnostics Market, by End User

12. Pre & Post Covid-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. Molecular Diagnostics Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Molecular Diagnostics Market, Key Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Agilent Technologies Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 F. Hoffmann-La Roche Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Qiagen NV
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 bioMerieux SA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Illumina Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Danaher
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Siemens Healthineers AG
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Novartis AG
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 TBG Diagnostics Limited
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Molecular Diagnostics Market Segmentation
  • Table 2. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 3. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 4. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 7. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 9. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 12. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 14. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 18. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 19. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 20. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 21. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 23. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 24. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 25. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 26. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 27. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Disease Area
  • Table 28. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 29. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 30. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 31. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 32. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 33. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 34. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 35. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 36. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 37. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 38. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 39. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 40. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 41. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 42. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 43. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 44. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 45. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 46. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 47. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 48. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 49. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 50. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 51. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 52. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 53. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 54. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 55. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 56. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 57. Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 58. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 59. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 60. Asia PAcific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 61. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 62. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 63. China Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 64. China Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 65. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 66. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 67. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 68. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 69. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 70. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 71. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 72. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 73. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 74. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 75. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 76. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 77. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 78. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 79. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 80. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 81. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 82. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 83. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 84. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 85. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 86. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 87. Singapore Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 88. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 89. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 90. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 91. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 92. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 93. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 94. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 95. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 96. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 97. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 98. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 99. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 100. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 101. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 102. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 103. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 104. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 105. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 106. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 107. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 108. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 109. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 110. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 111. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 112. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 113. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 114. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 115. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 116. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 117. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 118. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 119. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 120. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 121. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 122. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 123. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 124. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 125. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 126. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 127. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 128. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 129. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 130. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 131. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 132. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 133. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 134. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 135. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 136. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 137. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 138. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 139. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 140. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 141. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 142. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 143. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 144. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 145. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 146. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 147. South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 148. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 149. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 150. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 151. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 152. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 153. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 154. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 155. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 156. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 157. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 158. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 159. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 160. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 161. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 162. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
  • Table 163. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
  • Table 164. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 165. Rest of South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 166. Rest of South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 167. Organic Developments Done By Companies
  • Table 168. Inorganic Developments Done By Companies
  • Table 169. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. North America - PEST Analysis
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Asia Pacific - PEST Analysis
  • Figure 4. South & Central America - PEST Analysis
  • Figure 5. Middle East & Africa - PEST Analysis
  • Figure 6. Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 7. Impact Analysis of Drivers and Restraints
  • Figure 8. Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 9. Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 10. Oncology: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cardiac Diseases: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Immune System Disorders: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 17. PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. RT-PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. qPCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Multiplex PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. DNA microarrays: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. In-Situ Hybridization (ISH): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 28. Assays and Kits: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Instruments: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Services and Software: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 32. Hospitals and Clinics: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Ambulatory Surgical Centers: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Research and Academic Institutes: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Molecular Diagnostics Market, 2022 ($Mn)
  • Figure 37. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 39. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 41. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 42. Europe Molecular Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 43. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 45. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 48. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 49. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 50. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 51. Molecular Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 52. Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 53. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 54. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 55. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 56. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 57. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 58. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 59. Singapore Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 60. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 61. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 62. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 63. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 64. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 65. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 66. Molecular Diagnostics Market, By Geography, 2022 And 2030 ($Mn)
  • Figure 67. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 68. Middle East & Africa Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 69. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 70. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 71. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 72. Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 73. Molecular Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 74. South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 75. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 76. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 77. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 78. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 79. Pre & Post Covid-19 Impact
  • Figure 80. Growth Strategies Done by the Companies in the Market (%)